(Circulation. 2005;112:2851-2856.)
© 2005 American Heart Association, Inc.
Stroke |
From the Departments of Neurology (A.M.N., K.T.K., N.J., N.D.O., A.P., C.C., B.-F.M.F., S.A.M.) and Neurosurgery (A.P., C.C., B.-F.M.F., E.S.C., S.A.M.), Columbia University College of Physicians and Surgeons, New York, NY.
Reprint requests to Stephan A. Mayer, MD, Neurological Institute, 710 W 168th St, Box 39, New York, NY 10025. E-mail sam14{at}columbia.edu
Received January 3, 2005; revision received June 16, 2005; accepted July 25, 2005.
Background Cardiac troponin I (cTI) release occurs frequently after subarachnoid hemorrhage (SAH) and has been associated with a neurogenic form of myocardial injury. The prognostic significance and clinical impact of these elevations remain poorly defined.
Methods and Results We studied 253 SAH patients who underwent serial cTI measurements for clinical or ECG signs of potential cardiac injury. These patients were drawn from an inception cohort of 441 subjects enrolled in the Columbia University SAH Outcomes Project between November 1998 and August 2002. Peak cTI levels were divided into quartiles or classified as undetectable. Adverse in-hospital events were prospectively recorded, and outcome at 3 months was assessed with the modified Rankin Scale. Admission predictors of cTI elevation included poor clinical grade, intraventricular hemorrhage, loss of consciousness at ictus, global cerebral edema, and a composite score of physiological derangement (all P
0.01). Peak cTI level was associated with an increased risk of echocardiographic left ventricular dysfunction (odds ratio [OR], 1.3 per quintile; 95% CI, 1.0 to 1.7; P=0.03), pulmonary edema (OR, 2.1 per quintile; 95% CI, 1.6 to 2.7; P<0.001), hypotension requiring pressors (OR, 1.9 per quintile; 95% CI, 1.5 to 2.3; P<0.001), and delayed cerebral ischemia from vasospasm (OR, 1.3 per quintile; 95% CI, 1.07 to 1.7; P=0.01). Peak cTI levels were predictive of death or severe disability at discharge after controlling for age, clinical grade, and aneurysm size (adjusted OR, 1.4 per quintile; 95% CI, 1.1 to 1.9; P=0.02), but this association was no longer significant at 3 months.
Conclusions cTI elevation after SAH is associated with an increased risk of cardiopulmonary complications, delayed cerebral ischemia, and death or poor functional outcome at discharge.
Key Words: aneurysm cerebral infarction echocardiography subarachnoid hemorrhage troponin I
This article has been cited by other articles:
![]() |
A. Hakeem, A. D. Marks, S. Bhatti, and S. M. Chang When the Worst Headache Becomes the Worst Heartache! Stroke, December 1, 2007; 38(12): 3292 - 3295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramaraj Stress cardiomyopathy: aetiology and management Postgrad. Med. J., August 1, 2007; 83(982): 543 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Priebe Aneurysmal subarachnoid haemorrhage and the anaesthetist Br. J. Anaesth., July 1, 2007; 99(1): 102 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hessel II The brain and the heart. Anesth. Analg., September 1, 2006; 103(3): 522 - 526. [Full Text] [PDF] |
||||
![]() |
J. G. Zaroff, L. Pawlikowska, J. C. Miss, S. Yarlagadda, C. Ha, A. Achrol, P.-Y. Kwok, C. E. McCulloch, M. T. Lawton, N. Ko, et al. Adrenoceptor Polymorphisms and the Risk of Cardiac Injury and Dysfunction After Subarachnoid Hemorrhage Stroke, July 1, 2006; 37(7): 1680 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Naidech Adrenoreceptor Polymorphisms and Subarachnoid Hemorrhage Stroke, July 1, 2006; 37(7): 1635 - 1635. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |